700 patients110,866 observations180 daysLIVE

Patient P-02491

Synthetic patientMETA-24 · Day 175 · 25–34 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S09
  2. Day 39 DT-01 recommendedDosing / Timing Recommendation DT-01
  3. Day 40 Patient acceptedStarted DT-01 in the companion
  4. Day 45 No meaningful changeDosing / Timing Recommendation DT-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity-15
  • Nutritional resilience+5
  • Treatment adherence-4
  • Inflammatory activity-2

What helped?

  • Dosing / Timing Recommendation DT-01Day 39
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
27 min
worsening · -2.3 vs previous 14 d
Sleep duration
Wearable
6.5 h
worsening · -0.3 vs previous 14 d
Energy level
Daily log
5.5/10
worsening · -0.3 vs previous 14 d
Steps
Wearable
3,569
stable · -131 vs previous 14 d
GI burden
Companion
31.3/100
worsening · +7.1 vs previous 14 d
Adherence
Companion
92.9 %
stable · -1.1 vs previous 14 d
Sleep quality
Wearable
42.3/100
worsening · -5.3 vs previous 14 d
Glucose, CGM daily mean
CGM
128 mg/dL
stable · -0.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 66 from the failing basin, 21 from restoration.

Good elements to keep
  • Butyrate producers intact
    hidden · steering +7.5
  • Protein (supports)
    perturbation · steering +6.8
  • Daily walks resumed
    perturbation · steering +3.3
  • Dosing / Timing Recommendation DT-01
    intervention · steering +1.7
  • Protein
    supporter · GI -3.6 next day
Main detractors to watch
  • Rapid metabolizer
    hidden · steering -8
  • IL6 high-expression variant
    hidden · steering -7.3
  • Ultra-processed food
    perturbation · steering -3.7
  • Alcohol on dosing days
    perturbation · steering -1.8
  • Ultra-processed food
    detractor · GI +2 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -3.6supporter · 95%
  • Ultra-processed food
    +2detractor · 77%
  • Alcohol
    +1.5no signal · 46%
  • Dietary fat load
    +1.4no signal · 44%
  • Insoluble fibre
    +1no signal · 29%
  • Histamine load
    +0.5no signal · 16%
  • Caffeine
    -0.3no signal · 15%
  • Simple carbohydrates
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 25
    • DNAIL6 -174 variant raises baseline inflammatory tone
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery 20
    • Wearable3,569 steps/day
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Rapid metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 4.2 · butyrate capacity 64/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
38 ms
Sleep
6.0 h
Steps
4,675
Resting HR
60 bpm
Daily log: GI score 31, nutritional resilience 59, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0235334%S0483
P-0226133%S1383
P-0255433%S1982
P-0245433%S1779
P-0246635%S2079
P-0248233%S1479
P-0247833%S1979
P-0256533%S09DT-01no change79
P-0235442%S01CR-01improved78
P-0238533%S1178
P-0204845%S0277
P-0213534%S2077